These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 28767206)

  • 1. Psychostimulant Use in Schizophrenia for Treatment of Negative Symptoms and Weight Loss.
    Wahid N; Kim JJ; Bota RG
    Prim Care Companion CNS Disord; 2017 Jul; 19(4):. PubMed ID: 28767206
    [No Abstract]   [Full Text] [Related]  

  • 2. Three case reports of modafinil use in treating sedation induced by antipsychotic medications.
    Makela EH; Miller K; Cutlip WD
    J Clin Psychiatry; 2003 Apr; 64(4):485-6. PubMed ID: 12716260
    [No Abstract]   [Full Text] [Related]  

  • 3. A systematic review of psychostimulant treatment of negative symptoms of schizophrenia: challenges and therapeutic opportunities.
    Lindenmayer JP; Nasrallah H; Pucci M; James S; Citrome L
    Schizophr Res; 2013 Jul; 147(2-3):241-52. PubMed ID: 23619055
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Provocative tests with psychostimulant drugs in schizophrenia.
    Lieberman JA; Kane JM; Alvir J
    Psychopharmacology (Berl); 1987; 91(4):415-33. PubMed ID: 2884687
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adjunctive armodafinil for negative symptoms in adults with schizophrenia: a double-blind, placebo-controlled study.
    Kane JM; Yang R; Youakim JM
    Schizophr Res; 2012 Mar; 135(1-3):116-22. PubMed ID: 22178084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Antipsychotic agents and stimulants: a judicious combination?].
    de Jong MH; Eussen ML; van Gool AR
    Tijdschr Psychiatr; 2010; 52(1):57-61. PubMed ID: 20054798
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent psychostimulant use in hospitalized schizophrenics.
    Richard ML; Liskow BI; Perry PJ
    J Clin Psychiatry; 1985 Mar; 46(3):79-83. PubMed ID: 2857708
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful use of add-on minocycline for treatment of persistent negative symptoms in schizophrenia.
    Jhamnani K; Shivakumar V; Kalmady S; Rao NP; Venkatasubramanian G
    J Neuropsychiatry Clin Neurosci; 2013; 25(1):E06-7. PubMed ID: 23487204
    [No Abstract]   [Full Text] [Related]  

  • 9. Zonisamide-induced weight loss in schizophrenia: case series.
    Yang J; Lee MS; Joe SH; Jung IK; Kim SH
    Clin Neuropharmacol; 2010; 33(2):104-6. PubMed ID: 19935403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Switching patients from olanzapine or risperidone to a combination treatment using perphenazine plus buspirone: evaluation of antipsychotic efficacy and side-effects, including extrapyramidal effects and weight loss.
    Andersen TH; Bech P; Larsen NE
    Nord J Psychiatry; 2005; 59(3):205-8. PubMed ID: 16195121
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emotional processing in schizophrenia.
    Kohler CG; Martin EA
    Cogn Neuropsychiatry; 2006 May; 11(3):250-71. PubMed ID: 17354071
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Schizophrenia drug gets negative results for negative symptoms.
    Kingwell K
    Nat Rev Drug Discov; 2014 Apr; 13(4):244-5. PubMed ID: 24687052
    [No Abstract]   [Full Text] [Related]  

  • 13. Commentary on: "Differential effects of amphetamine and neuroleptics on negative vs. positive symptoms in schizophrenia." Psychopharmacology (1980) 72:17-19.
    Angrist B; Rotrosen J; Gershon S
    Psychopharmacology (Berl); 2001 Nov; 158(3):219-21. PubMed ID: 11713609
    [No Abstract]   [Full Text] [Related]  

  • 14. Amphetamine improves cognitive function in medicated individuals with schizophrenia and in healthy volunteers.
    Barch DM; Carter CS
    Schizophr Res; 2005 Sep; 77(1):43-58. PubMed ID: 16005384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mirtazapine add-on improves olanzapine effect on negative symptoms of schizophrenia.
    Caforio G; Di Giorgio A; Rampino A; Rizzo M; Romano R; Taurisano P; Fazio L; De Simeis G; Ursini G; Blasi G; Nardini M; Mancini M; Bertolino A
    J Clin Psychopharmacol; 2013 Dec; 33(6):810-2. PubMed ID: 24113675
    [No Abstract]   [Full Text] [Related]  

  • 16. Treatment of schizophrenia negative symptoms: future prospects.
    Erhart SM; Marder SR; Carpenter WT
    Schizophr Bull; 2006 Apr; 32(2):234-7. PubMed ID: 16492797
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Typology of therapy-resistant states in schizophrenia].
    Neduba AA
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1986; 86(3):424-8. PubMed ID: 2871683
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does atypical antipsychotic medication improve executive function in schizophrenia?
    Collie A; Maruff P; Snyder PJ
    Int J Neuropsychopharmacol; 2006 Oct; 9(5):629-30; author reply 631-2. PubMed ID: 16893492
    [No Abstract]   [Full Text] [Related]  

  • 19. A weight off the mind: Clozapine and profound weight loss.
    Webster A; Ingram L
    Aust N Z J Psychiatry; 2013 Dec; 47(12):1212-3. PubMed ID: 23881075
    [No Abstract]   [Full Text] [Related]  

  • 20. [Longterm treatment of schizophrenia].
    Pajonk VF
    MMW Fortschr Med; 2006 Jan; 148(4):35-8. PubMed ID: 16502798
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.